The Efficacy and Safety of Irbesartan/HCTZ Combination Therapy as First Line Treatment for Severe Hypertension
The Efficacy and Safety of Irbesartan/HCTZ Combination Therapy as First Line Treatment for Severe Hypertension
The purpose of this clinical research is to learn if severe hypertension can be better controlled by initially treating with a combination of drugs (Irbesartan/HCTZ), in patients who are unlikely to achieve blood pressure (B/P) control with only one drug. In addition, the study will also evaluate the safety and tolerability of the drugs.
Inclusion Criteria:
Exclusion Criteria:
Raleigh, California, United States
Rolling Hills Estate, California, United States
Charlotte Harbour, Florida, United States
Orangeburg, Oregon, United States
Niagra Falls, Ontario, Canada
Ste-Foy, Quebec, Canada
Longue, France
Rijswyk Zh, Netherlands